Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Capital Employed (2021 - 2023)

Terns Pharmaceuticals' Return on Capital Employed history spans 3 years, with the latest figure at 0.32% for Q3 2023.

  • For Q3 2023, Return on Capital Employed rose 5.0% year-over-year to 0.32%; the TTM value through Sep 2023 reached 0.32%, up 5.0%, while the annual FY2022 figure was 0.28%, 12.0% up from the prior year.
  • Return on Capital Employed reached 0.32% in Q3 2023 per TERN's latest filing, down from 0.26% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.22% in Q2 2021 to a low of 0.37% in Q2 2022.
  • Average Return on Capital Employed over 3 years is 0.29%, with a median of 0.3% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: dropped -15bps in 2022, then grew 11bps in 2023.
  • A 3-year view of Return on Capital Employed shows it stood at 0.3% in 2021, then rose by 10bps to 0.27% in 2022, then fell by -19bps to 0.32% in 2023.
  • Per Business Quant, the three most recent readings for TERN's Return on Capital Employed are 0.32% (Q3 2023), 0.26% (Q2 2023), and 0.25% (Q1 2023).